4.7 Article

Outcomes and Incidence of PF-ILD According to Different Definitions in a Real-World Setting

Related references

Note: Only part of the references are listed.
Review Respiratory System

Progression of fibrosing interstitial lung disease

Alyson W. Wong et al.

RESPIRATORY RESEARCH (2020)

Article Medicine, General & Internal

Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management

Marlies Wijsenbeek et al.

CURRENT MEDICAL RESEARCH AND OPINION (2019)

Article Medicine, General & Internal

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

K. R. Flaherty et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Respiratory System

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases

Sebastiano Emanuele Torrisi et al.

BMC PULMONARY MEDICINE (2019)

Review Respiratory System

The natural history of progressive fibrosing interstitial lung diseases

Martin Kolb et al.

RESPIRATORY RESEARCH (2019)

Meeting Abstract Respiratory System

Late Breaking Abstract - Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF)

Andreas Guenther et al.

EUROPEAN RESPIRATORY JOURNAL (2019)

Article Critical Care Medicine

Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

Ganesh Raghu et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Review Critical Care Medicine

Acute Exacerbation of Idiopathic Pulmonary Fibrosis An International Working Group Report

Harold R. Collard et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)